– Endocrinology clinical development progress and research in growth hormone deficiency, hypoparathyroidism, achondroplasia, and Turner Syndrome will be highlighted – Phase 3 Week 52 data for TransCon™ PTH in adults with hypoparathyroidism selected for oral presentation COPENHAGEN, Denmark, June 13, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced it will showcase its latest Endocrinology Rare […]

Akoustis’ Foundry Services Offers Custom 150-mm RF MEMS Silicon (Si) Substrate Fabrication Capabilities for RF Resonators and Filters Launches Fully Automated PDK Incorporating Artificial Intelligence (AI)-Enabled Software for Chip Design Expands Available Market Enabling Broad Selection of Customers the Ability to Utilize XBAW® Process Charlotte, N.C., June 13, 2023 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: […]

Heineken® is marking its 150th Anniversary with an unconventional celebration that prioritises good times over getting it right Haikenen? Aineken? Heineken®? Spelling it correctly won’t create good times, but the world’s most international beer brand knows what can. Heineken® is marking its 150th Anniversary with an unconventional celebration that prioritises good times over getting it […]

Toast will now enable enterprise merchants to combine FreedomPay’s best-in-class global Commerce Platform with its leading restaurant digital platform Philadelphia, Pennsylvania, June 12, 2023 (GLOBE NEWSWIRE) — FreedomPay, the world’s leading independent commerce platform and Toast, the all-in-one digital platform built for the entire restaurant community, signed a partnership agreement making FreedomPay Toast’s preferred payments […]

Funding will accelerate Cohere’s leadership position giving enterprises the power of AI on the cloud platform of their choice, keeping their data private and secure SAN FRANCISCO and TORONTO, June 08, 2023 (GLOBE NEWSWIRE) — Cohere, the leading AI platform for enterprise, today announced $270M in new capital as part of its Series C financing. […]